Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Genes Immun ; 2(2): 76-81, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11393660

ABSTRACT

Scleroderma is a condition of variable phenotype characterised by fibrosis of the skin and internal organs. There is a range of disease-specific autoantibodies found in the sera of patients. The aims of this study were to: (1) investigate the role of the MHC and particularly HLA-DP in the production of autoantibodies; (2) investigate clinical associations with autoantibodies. We have performed HLA class II typing using PCR with sequence-specific primers on DNA samples from 202 scleroderma patients and 307 UK control subjects. All patients had well defined clinical phenotypes. Sera from patients were examined for the presence of disease specific autoantibodies in particular the anti-topoisomerase autoantibody (ATA), the anti-centromere autoantibody (ACA) and the anti-RNA polymerase autoantibody (ARA). There was a striking association between HLA-DPB1*1301 and ATA (Pcorr = 0.0001). In addition, ATA was associated with HLA-DRB1*11 and the anticentromere autoantibody (ACA) with HLA-DRB1*04, HLA-DRB1*08 (P = 0.001) and HLA-DQB1 alleles with a glycine residue at position 26. Very strong associations were detected between clinical phenotypes and autoantibodies. ATA was associated with pulmonary fibrosis (P = 0.00002), anti-RNA polymerase autoantibody (ARA) with renal involvement (P = 0.0000006) and diffuse skin disease (P = 0.00001), and ACA with limited skin involvement (P = 0.00002) and protection against pulmonary fibrosis (P = 0.0000003). We have identified a significant association between the ATA and HLA-DPB1*1301 which may provide an insight into how this autoantibody is formed. Patient clinical characteristics depend on the autoantibodies they carry.


Subject(s)
Autoantibodies/blood , DNA Topoisomerases, Type I/immunology , Genes, MHC Class II , HLA-DP Antigens/genetics , Scleroderma, Systemic/immunology , Case-Control Studies , DNA-Directed RNA Polymerases/immunology , Genotype , HLA-DP beta-Chains , Humans , Phenotype , Polymerase Chain Reaction/methods , Scleroderma, Systemic/genetics , Scleroderma, Systemic/physiopathology , United Kingdom , White People
2.
Eur Respir J ; 16(1): 67-73, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10933087

ABSTRACT

The aim of this study was to investigate the effect on lung function of lung biopsy used in the diagnosis of diffuse lung disease carried out by an open procedure or by video-assisted thoracoscopy. One hundred and sixteen patients with diffuse lung disease who attended the Royal Brompton Hospital were studied retrospectively. Thirty five patients underwent open lung biopsy, and 33 video-assisted thoracoscopic biopsy and 48 had their diagnosis made without biopsy. All patients underwent lung function tests before and after surgery, or at an interval of 3-6 months in those who did not undergo biopsy. No significant differences were found in changes in lung function between those who had and had not undergone biopsy, and the proportions of patients whose lung function improved or deteriorated were similar. Lung biopsy by an open procedure or by video-assisted thoracoscopy did not differ in its effects on lung function. The results for older patients, those with severe disease and those with fibrosing alveolitis were the same as for the whole group. Open lung biopsy for the diagnosis of diffuse lung disease does not deleteriously affect lung function whether carried out by an open or a minimally invasive procedure.


Subject(s)
Biopsy , Lung Diseases, Interstitial/physiopathology , Lung/pathology , Respiratory Mechanics , Thoracic Surgery, Video-Assisted , Adult , Aged , Aged, 80 and over , Biopsy/adverse effects , Female , Forced Expiratory Volume , Humans , Lung Diseases, Interstitial/diagnosis , Male , Middle Aged , Pulmonary Diffusing Capacity , Total Lung Capacity , Vital Capacity
3.
Am J Respir Crit Care Med ; 160(3): 899-905, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10471616

ABSTRACT

This study aimed to investigate whether there was a difference in outcome related to histologic pattern in cryptogenic fibrosing alveolitis (CFA) and to see whether there were correlations between clinical and radiologic findings and histology. One hundred thirteen lung biopsies from consecutive patients taken for the diagnosis of diffuse lung disease were reviewed and reclassified using the Katzenstein and Myers criteria for interstitial pneumonias. Patients lacking full investigational data at presentation and those with conditions predisposing to lung fibrosis were excluded, leaving 15 patients diagnosed with nonspecific interstitial pneumonia (NSIP) and 15 with usual interstitial pneumonia (UIP). Clinical and radiologic findings at presentation and serial lung function information and survival status in November 1998 were compared for the two groups. Survival was found to be significantly greater in the NSIP group compared with the UIP group (p < 0.001). This could not be explained by differences in treatment. Patients with UIP showed a progressive deterioration in lung function whereas those with NSIP remained stable. CT scans of patients with UIP showed more fibrosis than those of patients with NSIP (p < 0.011). A histologic diagnosis of NSIP is associated with a better prognosis than UIP. This subclassification of CFA is clinically useful.


Subject(s)
Lung Diseases, Interstitial/pathology , Pulmonary Fibrosis/pathology , Adult , Aged , Biopsy , Bronchoalveolar Lavage , Chi-Square Distribution , Female , Humans , Lung Diseases, Interstitial/classification , Lung Diseases, Interstitial/drug therapy , Male , Middle Aged , Prognosis , Pulmonary Fibrosis/classification , Pulmonary Fibrosis/drug therapy , Respiratory Function Tests , Statistics, Nonparametric , Survival Analysis , Tomography, X-Ray Computed/methods , Treatment Outcome
4.
Tissue Antigens ; 51(1): 51-61, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9459503

ABSTRACT

HLA-DP is the third of the class II molecules. Its role is antigen presentation, and it has been suggested to play a part in the susceptibility to certain diseases such as berylliosis, sarcoidosis and juvenile chronic arthritis. The standard typing method is SSO typing, although other methods have been used. Probably the best is sequence-based typing, but this is time-consuming and requires expensive equipment. We describe a method for comprehensive HLA-DPB1 and HLA-DPA1 typing using sequence-specific primers. This method has the advantages that it is rapid - typing a single DNA sample takes under 3 hours - and does not require any special equipment or reagents. The method has been shown to be highly accurate by typing 60 cell line DNA samples in which there was 100% agreement between the types obtained and the published information. Similarly typing of 20 DNA samples previously typed by sequence-based typing gave 100% concordance. We used the method to type DNA samples from 102 UK Caucasoid kidney donors. The allele frequencies agree with previously published data. Linkage disequilibria between HLA-DPB1, HLA-DPA1 and the other class II antigens have been investigated. Strong linkage disequilibria exist between certain HLA-DPB1 and HLA-DPA1 alleles. This is unsurprising in view of their proximity on the chromosome. More unexpectedly, the data also suggest that genes further away along the chromosome are in linkage disequilibrium with HLA-DP, forming extended haplotypes.


Subject(s)
DNA Primers , HLA-DP Antigens/genetics , Polymerase Chain Reaction/methods , HLA-DP Antigens/classification , HLA-DP alpha-Chains , HLA-DP beta-Chains , Histocompatibility Testing , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...